Literature DB >> 20729348

Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues.

Satori A Marchitti1, David J Orlicky, Chad Brocker, Vasilis Vasiliou.   

Abstract

Aldehyde dehydrogenase (ALDH) enzymes are critical in the detoxification of endogenous and exogenous aldehydes. Our previous findings indicate that the ALDH3B1 enzyme is expressed in several mouse tissues and is catalytically active toward aldehydes derived from lipid peroxidation, suggesting a potential role against oxidative stress. The aim of this study was to elucidate by immunohistochemistry the tissue, cellular, and subcellular distribution of ALDH3B1 in normal human tissues and in tumors of human lung, colon, breast, and ovary. Our results indicate that ALDH3B1 is expressed in a tissue-specific manner and in a limited number of cell types, including hepatocytes, proximal convoluted tubule cells, cerebellar astrocytes, bronchiole ciliated cells, testis efferent ductule ciliated cells, and histiocytes. ALDH3B1 expression was upregulated in a high percentage of human tumors (lung > breast = ovarian > colon). Increased ALDH3B1 expression in tumor cells may confer a growth advantage or be the result of an induction mechanism mediated by increased oxidative stress. Subcellular localization of ALDH3B1 was predominantly cytosolic in tissues, with the exception of normal human lung and testis, in which localization appeared membrane-bound or membrane-associated. The specificity of ALDH3B1 distribution may prove to be directly related to the functional role of this enzyme in human tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729348      PMCID: PMC2924794          DOI: 10.1369/jhc.2010.955773

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  97 in total

1.  Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics.

Authors:  A Yokoyama; T Muramatsu; T Omori; T Yokoyama; S Matsushita; S Higuchi; K Maruyama; H Ishii
Journal:  Carcinogenesis       Date:  2001-03       Impact factor: 4.944

2.  Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes, apparently as a consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5'-upstream regions of these genes.

Authors:  L Sreerama; N E Sládek
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

3.  Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.

Authors:  Norman E Sládek; Rahn Kollander; Lakshmaiah Sreerama; David T Kiang
Journal:  Cancer Chemother Pharmacol       Date:  2002-02-13       Impact factor: 3.333

4.  Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin.

Authors:  J S Wang; Q Fang; D J Sun; J Chen; X L Zhou; G W Lin; H Z Lu; J Fei
Journal:  Acta Pharmacol Sin       Date:  2001-10       Impact factor: 6.150

5.  Metabolism of 4-hydroxynonenal by rat Kupffer cells.

Authors:  S W Luckey; D R Petersen
Journal:  Arch Biochem Biophys       Date:  2001-05-01       Impact factor: 4.013

6.  Discovery of novel targets of quinoline drugs in the human purine binding proteome.

Authors:  Paul R Graves; Jesse J Kwiek; Patrick Fadden; Rupa Ray; Klaas Hardeman; Andrew M Coley; Michael Foley; Timothy A J Haystead
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

7.  Ethanol metabolism and transcription factor activation in pancreatic acinar cells in rats.

Authors:  Anna S Gukovskaya; Michelle Mouria; Ilya Gukovsky; Chistopher N Reyes; Vladimir N Kasho; Larry D Faller; Stephen J Pandol
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

Review 8.  NAD(P)H, a directly operating antioxidant?

Authors:  M Kirsch; H De Groot
Journal:  FASEB J       Date:  2001-07       Impact factor: 5.191

9.  Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Authors:  Jun Luo; Shan Zha; Wesley R Gage; Thomas A Dunn; Jessica L Hicks; Christina J Bennett; Charles M Ewing; Elizabeth A Platz; Sacha Ferdinandusse; Ronald J Wanders; Jeffrey M Trent; William B Isaacs; Angelo M De Marzo
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

10.  10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells.

Authors:  Sergey A Krupenko; Natalia V Oleinik
Journal:  Cell Growth Differ       Date:  2002-05
View more
  29 in total

1.  Aldehyde dehydrogenase isoforms and inflammatory cell populations are differentially expressed in term human placentas affected by intrauterine growth restriction.

Authors:  Alison Chu; Parisa Najafzadeh; Peggy Sullivan; Brian Cone; Ryan Elshimali; Hania Shakeri; Carla Janzen; Vei Mah; Madhuri Wadehra
Journal:  Placenta       Date:  2019-04-08       Impact factor: 3.481

2.  Aldehyde dehydrogenase isozymes: markers of cancer stem cells in human melanoma.

Authors:  Nicholas Nguyen; Yuchun Luo; Mayumi Fujita
Journal:  Expert Rev Dermatol       Date:  2013

3.  Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.

Authors:  Ying Chen; David J Orlicky; Akiko Matsumoto; Surendra Singh; David C Thompson; Vasilis Vasiliou
Journal:  Biochem Biophys Res Commun       Date:  2011-01-07       Impact factor: 3.575

4.  Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases.

Authors:  Jun-Xiang Zhang; Da-Qiang Li; Aiwu Ruth He; Mona Motwani; Vasilis Vasiliou; Jeyanthy Eswaran; Lopa Mishra; Rakesh Kumar
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

5.  Molecular characterization, expression analysis, and role of ALDH3B1 in the cellular protection against oxidative stress.

Authors:  Satori A Marchitti; Chad Brocker; David J Orlicky; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2010-08-10       Impact factor: 7.376

Review 6.  Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells.

Authors:  Vasilis Vasiliou; David C Thompson; Clay Smith; Mayumi Fujita; Ying Chen
Journal:  Chem Biol Interact       Date:  2012-11-16       Impact factor: 5.192

7.  Pathways of retinoid synthesis in mouse macrophages and bone marrow cells.

Authors:  Haixia Niu; Gayla Hadwiger; Hideji Fujiwara; John S Welch
Journal:  J Leukoc Biol       Date:  2016-01-14       Impact factor: 4.962

8.  Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.

Authors:  Wenjing Song; Xin He; Pengju Gong; Yan Yang; Sirui Huang; Yifan Zeng; Lei Wei; Jingwei Zhang
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

9.  Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures.

Authors:  Yu-Ting Saw; Junzheng Yang; Shu-Kay Ng; Shubai Liu; Surendra Singh; Margit Singh; William R Welch; Hiroshi Tsuda; Wing-Ping Fong; David Thompson; Vasilis Vasiliou; Ross S Berkowitz; Shu-Wing Ng
Journal:  BMC Cancer       Date:  2012-08-01       Impact factor: 4.430

10.  Identification of potential biomarkers from microarray experiments using multiple criteria optimization.

Authors:  Matilde L Sánchez-Peña; Clara E Isaza; Jaileene Pérez-Morales; Cristina Rodríguez-Padilla; José M Castro; Mauricio Cabrera-Ríos
Journal:  Cancer Med       Date:  2013-02-27       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.